Phases of Acute Hepatitis B Infection
Acute hepatitis B infection follows a distinct temporal pattern characterized by an incubation period of 1-4 months (range: 6 weeks to 6 months), followed by a symptomatic phase lasting 2-4 months in those who develop clinical illness, with most infections in adults resolving spontaneously. 1
Incubation Phase (Pre-symptomatic Period)
- Duration: 2-3 months on average after HBV exposure, with a range of 6 weeks to 6 months 1
- Viral dynamics: HBV replicates rapidly with doubling times of 2.2 to 5.8 days (mean 3.7 days), reaching peak viral loads of nearly 10^10 HBV DNA copies/mL 2
- Immune response: HBV-specific CD4+ and CD8+ T cells are detectable at least 4 weeks before symptom onset, indicating adaptive immune mechanisms are active during incubation 3
- Clinical presentation: Patients are asymptomatic despite active viral replication and early immune responses 3
- ALT elevation: Liver enzyme elevation begins during late incubation, coinciding with initial viral decline, though maximal viral reduction occurs before significant liver injury 3
Symptomatic (Clinical) Phase
- Symptom onset: Clinical manifestations appear 2-3 months post-exposure in 30-50% of adults over age 5 years 1
- Age-related presentation: Only ~10% of children under 4 years develop symptoms, while ~30% of adults over 30 years become symptomatic 4
- Prodromal symptoms: Fatigue and loss of appetite typically precede jaundice by 1-2 weeks 1
- Classic symptoms: Include fatigue, poor appetite, nausea, vomiting, abdominal pain, low-grade fever, jaundice, dark urine, and light-colored stools 1
- Physical findings: Jaundice, liver tenderness, and possibly hepatomegaly or splenomegaly 1
- Duration: Acute illness typically lasts 2-4 months 1
Viral Clearance Phase
- Clearance pattern: HBV DNA follows a two or three-phase decay pattern after peak viremia 2
- Initial rapid decline: Mean half-life of 3.7 days, similar to noncytolytic clearance of covalently closed circular DNA 2
- Free virus clearance: Mean half-life of at most 1.2 days 2
- Final phase: Variable rate of virion clearance (half-life 4.8 to 284 days), likely related to the rate of infected hepatocyte loss 2
- Resolution: Self-limited infection with viral elimination and lasting immunity occurs in >90% of adults 1
Critical Pitfalls and Clinical Considerations
Age is the most critical determinant of outcome: The risk of progression to chronic infection is inversely related to age at infection—>90% of infected infants, 25-50% of children aged 1-5 years, but <5% of older children and adults develop chronic infection 1
Case-fatality rate: Approximately 1% overall, with highest rates (12%) in adults over 60 years 1
Immunosuppressed patients: Those with HIV infection or on hemodialysis have increased risk for chronic infection 1
Diagnostic approach: Acute hepatitis B is diagnosed through detection of viral proteins (HBsAg, HBeAg) and host antibodies (anti-HBc IgM), not molecular testing, except for pretransfusion screening 4
Peak viral production: Estimated at 10^13 virions/day, with infected hepatocytes producing 200-1,000 virions/day on average, creating conditions where every possible single mutation and most double mutations occur daily 2